Anthem Biosciences Limited

Viridity Tone LLP sold 2,03,13,795 shares of Anthem Biosciences for ₹1255.25 Cr at ₹617.93 apiece in a market sale, reducing its stake from 3.79% to 0.18%. This marks a near full exit.

A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.